Publication | Closed Access

The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses

VaccinationVaccinologyPulmonary TuberculosisVaccine DevelopmentMedicineTuberculosis PreventionImmunologyTuberculosisCd8t Cell ResponsesCd4 T Cell ResponsesNovel Tuberculosis VaccineHealthy InfantsVaccine Research